These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33336020)

  • 1. CXCL13 concentration in latent syphilis patients with treatment failure.
    Zhang Y; Wang J; Wei Y; Liu H; Wu C; Qu B; Yan Y
    Open Med (Wars); 2020; 15(1):635-643. PubMed ID: 33336020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
    Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
    Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
    Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
    Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
    Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
    Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL13, CXCL10 and CXCL8 as Indicators of Ocular and Neurological Involvement in Patients With Ocular Syphilis: An Observational Descriptive Study.
    van der Merwe LW; Snyders C; Kidd M; Chegou NN; Walzl G; Smit DP
    Front Ophthalmol (Lausanne); 2022; 2():916718. PubMed ID: 38983560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
    Zeng YL; Lin YQ; Zhang NN; Zou CN; Zhang HL; Peng F; Liu ZJ; Zheng WH; Yan JH; Liu LL
    Springerplus; 2016; 5(1):743. PubMed ID: 27376011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has CXCL13 an added value in diagnosis of neurosyphilis?
    Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
    J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of
    Yang L; Fu Y; Li S; Liu C; Liu D
    Infect Drug Resist; 2022; 15():7791-7798. PubMed ID: 36600952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
    Li D; Huang X; Shi M; Luo L; Tao C
    Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid Changes and Clinical Features of Neurosyphilis Compared with Latent Syphilis Infection in the Central Nervous System: A Cross-Sectional Study.
    Ge Y; Gou X; Dong X; Peng Y; Yang F
    Infect Drug Resist; 2022; 15():5377-5385. PubMed ID: 36110129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of neurosyphilis in human immunodeficiency virus-infected patients with latent syphilis.
    Holtom PD; Larsen RA; Leal ME; Leedom JM
    Am J Med; 1992 Jul; 93(1):9-12. PubMed ID: 1626576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment.
    Lukehart SA; Hook EW; Baker-Zander SA; Collier AC; Critchlow CW; Handsfield HH
    Ann Intern Med; 1988 Dec; 109(11):855-62. PubMed ID: 3056164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus.
    Dowell ME; Ross PG; Musher DM; Cate TR; Baughn RE
    Am J Med; 1992 Nov; 93(5):481-8. PubMed ID: 1442850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
    Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
    BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Treponema pallidum by semi-nested PCR in the cerebrospinal fluid of asymptomatic HIV-infected patients with latent syphilis.
    Fraga D; Muller AL; Czykiel MS; De Armas Y; Wissmann G; Goldani LZ
    Clin Lab; 2014; 60(12):2051-4. PubMed ID: 25651740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
    Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
    Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.
    Tsai HC; Ye SY; Kunin CM; Lee SS; Wann SR; Tai MH; Shi MH; Liu YC; Chen YS
    Cytokine; 2011 May; 54(2):109-16. PubMed ID: 21354815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of routine lumbar puncture in non-HIV patients with latent syphilis of unknown duration.
    Choe PG; Song JS; Song KH; Jeon JH; Park WB; Park KU; Park SW; Kim NJ; Oh MD; Kim HB
    Sex Transm Infect; 2010 Feb; 86(1):39-40. PubMed ID: 19837729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid treponemal antibodies in untreated early syphilis.
    Marra CM; Critchlow CW; Hook EW; Collier AC; Lukehart SA
    Arch Neurol; 1995 Jan; 52(1):68-72. PubMed ID: 7826278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE).
    Zajkowska J; Moniuszko-Malinowska A; Pancewicz SA; Muszyńska-Mazur A; Kondrusik M; Grygorczuk S; Swierzbińska-Pijanowska R; Dunaj J; Czupryna P
    Adv Med Sci; 2011; 56(2):311-7. PubMed ID: 22008312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.